Literature DB >> 33463238

Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure-Activity Relationships to Enhance Bactericidal Efficiency.

Peng Tan1, Zhenheng Lai1, Yongjie Zhu1, Changxuan Shao1, Muhammad Usman Akhtar1, Weifen Li2, Xin Zheng3, Anshan Shan1.   

Abstract

Unlike traditional broad-spectrum antibacterial agents, specifically targeted antimicrobial peptides (STAMPs) are difficult for bacteria to develop resistance to due to their unique membrane lytic mechanism. Additionally, STAMPs can maintain a normal ecological balance and provide long-term protection to the body. However, therapeutic applications of STAMPS are hindered by their weak activity and imperfect specificity, as well as lack of knowledge in understanding their structure-activity relationships. To investigate the effects of different parameters on the biological activities of STAMPs, a peptide sequence, WKKIWKDPGIKKWIK, was truncated, extended, and provided with an increased charge and altered amphipathicity. In addition, a novel template modification method for attaching a phage-displayed peptide, which recognized and bound to Escherichia coli (E. coli) cells, to the end of the sequence was introduced. Compared with the traditional template modification method, peptide 13, which contained a phage-displayed peptide at the C-terminus, exhibited superior narrow-spectrum antibacterial activity against E. coli compared to that of parental peptide 2, and the activity and specificity of peptide 13 were increased by 5.0 and 2.4 times, respectively. Additionally, peptide 13 showed low cytotoxicity and relatively desirable salt, serum, acid, alkaline and heat stability. In this study, peptide 13 specifically killed E. coli by causing cytoplasmic membrane rupture and cytosol leakage. In summary, these findings are useful for improving the activity and specificity of STAMPs and show that peptide 13 is able to combat the growing threat of E. coli infections.

Entities:  

Keywords:  activity; antibacterial mechanism; specifically targeted antimicrobial peptides; specificity

Mesh:

Substances:

Year:  2019        PMID: 33463238     DOI: 10.1021/acsbiomaterials.9b00937

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  6 in total

1.  C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo.

Authors:  Ting Li; Na Yang; Da Teng; Ruoyu Mao; Ya Hao; Xiumin Wang; Jianhua Wang
Journal:  BMC Microbiol       Date:  2022-05-12       Impact factor: 4.465

Review 2.  Engineering Selectively Targeting Antimicrobial Peptides.

Authors:  Ming Lei; Arul Jayaraman; James A Van Deventer; Kyongbum Lee
Journal:  Annu Rev Biomed Eng       Date:  2021-04-14       Impact factor: 11.324

3.  An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining.

Authors:  Licheng Liu; Caiyun Wang; Mengyue Zhang; Zixuan Zhang; Yingying Wu; Yixuan Zhang
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

4.  The Effects of Luminescent CdSe Quantum Dot-Functionalized Antimicrobial Peptides Nanoparticles on Antibacterial Activity and Molecular Mechanism.

Authors:  Wanzhen Li; Ping Song; Ying Xin; Zhao Kuang; Qin Liu; Fei Ge; Longbao Zhu; Xuguang Zhang; Yugui Tao; Weiwei Zhang
Journal:  Int J Nanomedicine       Date:  2021-03-05

5.  Designing Self-Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections.

Authors:  Peng Tan; Qi Tang; Shenrui Xu; Yucheng Zhang; Huiyang Fu; Xi Ma
Journal:  Adv Sci (Weinh)       Date:  2022-03-13       Impact factor: 17.521

6.  Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo.

Authors:  He Liu; Na Yang; Da Teng; Ruoyu Mao; Ya Hao; Xuanxuan Ma; Jianhua Wang
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.